PCPG clinical trials at UCLA

1 in progress, 0 open to eligible people

ONC206 (JZP3507) in Advanced Pheochromocytoma and Paraganglioma
Sorry, not yet accepting patients
This is a two-stage Phase 2 trial evaluating the efficacy and safety of ONC206 in participants with Pheochromocytoma and Paraganglioma (PCPG).
Los Angeles, California and other locations

Last updated: December 5, 2025